World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
49
Citations
8407
World Ranking
14840
National Ranking
1087

George L. Trainor publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where George L. Trainor sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 114 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

George L. Trainor D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where George L. Trainor sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 49 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

George L. Trainor is affiliated with Bristol-Myers Squibb in Germany. Their research spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with a focus on several subfields including Molecular Biology, Oncology, Genetics, Infectious Diseases, and Virology.

Their work covers diverse topics such as Cancer Treatment and Pharmacology, Glioma Diagnosis and Treatment, HIV/AIDS drug development and treatment, Biochemical and Molecular Research, HIV Research and Treatment, RNA Interference and Gene Delivery, and Protein Degradation and Inhibitors.

Trainor's recent publications include:

  • Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors, 2020, Journal of Medicinal Chemistry
  • XPO1-Targeting Selective Inhibitors of Transcriptional Activation Suppress Graft-versus-Host Disease, 2025, Journal of Medicinal Chemistry
  • EXTH-59. POTENT, SELECTIVE, AND BRAIN PENETRANT INHIBITORS OF EXTRACELLULAR DOMAIN EGFR ONCOGENIC MUTANTS EXPRESSED IN GBM DEMONSTRATE EFFICACY IN AN INTRACRANIAL PATIENT DERIVED XENOGRAFT MODEL, 2020, Neuro-Oncology
  • Abstract LB140: CNS penetrant, irreversible inhibitors potently inhibit the family of allosteric oncogenic EGFR mutants expressed in GBM and demonstrate efficacy in patient-derived xenograft models, 2021, Cancer Research
  • Abstract 6948: A PP2A molecular glue restores heterotrimer formation for the treatment of high-grade uterine cancers, 2025, Cancer Research

The primary publication venues where Trainor has contributed include:

  • Journal of Medicinal Chemistry
  • Cancer Research
  • Neuro-Oncology
  • Molecular Cancer Therapeutics

Frequent coauthors with whom Trainor has collaborated are:

  • Matthew O'Connor
  • Matt Lucas
  • Darlene Romashko
  • Sara Rasmussen
  • Raffaele Fiorenza

Best Publications

  • MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.

    John V. Duncia;Joseph B. Santella;C.Anne Higley;William J. Pitts

  • Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle Regulation

    Thais M. Sielecki;John F. Boylan;Pamela A. Benfield;George L. Trainor

  • The importance of plasma protein binding in drug discovery

    George L Trainor

  • Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily

    Gretchen M. Schroeder;Yongmi An;Zhen-Wei Cai;Xiao-Tao Chen

  • Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.

    Jeffrey W. Corbett;Soo S. Ko;James D. Rodgers;Lisa A. Gearhart

  • Optimization of metallocene substrates for .beta.-cyclodextrin reactions

    Ronald Breslow;George Trainor;Akihiko Ueno

  • Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinases.

    Jay A. Markwalder;Marc R. Arnone;Pamela A. Benfield;Michael Boisclair

  • High acylation rates and enantioselectivity with cyclodextrin complexes of rigid substrates

    George L. Trainor;Ronald Breslow

  • Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1

    Jeffrey W. Corbett;Soo S. Ko;James D. Rodgers;Susan Jeffrey

  • Matrix metalloproteinase–activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity

    Charles F. Albright;Nilsa Graciani;Wei Han;Eddy Yue

  • 4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist.

    Liqi He;Paul J. Gilligan;Robert Zaczek;Lawrence W. Fitzgerald

  • Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities.

    Kyoung Soon Kim;Liping Zhang;Robert Schmidt;Zhen-Wei Cai

  • Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development.

    Mark D. Wittman;Joan M. Carboni;Zheng Yang;Francis Y. Lee

  • Quinazolines as cyclin dependent kinase inhibitors.

    Thais M. Sielecki;Tricia L. Johnson;Jie Liu;Jodi K. Muckelbauer

  • The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist.

    Paul J. Gilligan;Caryn Baldauf;Anthony Cocuzza;Dennis Chidester

  • Organo-Transition-Metal-Based Approach to the Synthesis of C-Glycosides.

    P. Deshong;G. A. Slough;V. Elango;G. L. Trainor

  • Organo-transition-metal-based approach to the synthesis of C-glycosides

    Philip DeShong;Greg A. Slough;Varadaraj Elango;George L. Trainor

  • Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors.

    Mona Patel;Robert J McHugh;Beverly C Cordova;Ronald M Klabe

  • Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1).

    Tram Huynh;Zhong Chen;Suhong Pang;Jieping Geng

  • Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors.

    Ashvinikumar V. Gavai;Claude Quesnelle;Derek Norris;Wen-Ching Han

  • Trends in kinase selectivity: insights for target class-focused library screening.

    Shana L. Posy;Mark A. Hermsmeier;Wayne Vaccaro;Karl-Heinz Ott

Frequent Co-Authors

Marco M. Gottardis
Marco M. Gottardis NKGen Biotech Inc
John T. Hunt
John T. Hunt Bristol-Myers Squibb (Germany)
Robert A. Copeland
Robert A. Copeland Accent Therapeutics (United States)
Robert C. Newton
Robert C. Newton Incyte (United States)
Terra L. Lasho
Terra L. Lasho Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse career paths, especially in the interdisciplinary field of forensic science. Many students choose to build on their chemistry background by pursuing an online bachelor's degree in forensic science, which combines scientific expertise with criminal justice applications.

For those interested in deeper specialization, an online masters degree in forensic psychology offers advanced knowledge blending psychology and legal studies. This pathway complements chemical analysis skills with insights into human behavior and legal processes.

Specific roles such as forensic autopsy technicians benefit from targeted training. If you are wondering how to become an autopsy technician, an understanding of biology and chemistry is essential, alongside practical forensic experience.

Considering salary prospects can guide career decisions. Exploring the forensic science degree salary data helps students and professionals gauge potential earnings in various forensic roles, motivating informed choices in education and career development.

Best Scientists Citing George L. Trainor

Trending Scientists